Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report

Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe or 'the company') is a Japanese company that develops and sells pharmaceutical products. Mitsubishi Tanabe produces drugs for disease such as autoimmune, kidney disorders, central nervous system and diabetes. The company also manufactures products for other contagious diseases. Mitsubishi Tanabe's offers its products under brands such as Maintate, Tenelia, Remicade Simponi, Radicut, Ceredist, Lexapro, Nanpao, Talion, Flucort F and Tetrabik. It sells products to clinics, hospitals, drugstores and wholesalers. The company operates research centers in Saitama, Kanagawa and Osaka. The company has its presence across North America, Asia, and Europe. The company is headquartered in Chuo-ku, Osaka, Japan.

Scope

– Detailed information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis

– An in-depth view of the business model of Mitsubishi Tanabe Pharma Corporation including a breakdown and examination of key business segments

– Intelligence on Mitsubishi Tanabe Pharma Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Mitsubishi Tanabe Pharma Corporation, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mitsubishi Tanabe Pharma Corporation and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Mitsubishi Tanabe Pharma Corporation as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Mitsubishi Tanabe Pharma Corporation's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Mitsubishi Tanabe Pharma Corporation: Company Overview

Mitsubishi Tanabe Pharma Corporation: Overview and Key Facts

Mitsubishi Tanabe Pharma Corporation: Overview

Mitsubishi Tanabe Pharma Corporation: Key Facts

Mitsubishi Tanabe Pharma Corporation: Key Employees

Mitsubishi Tanabe Pharma Corporation: Key Employee Biographies

Mitsubishi Tanabe Pharma Corporation: Major Products and Services

Mitsubishi Tanabe Pharma Corporation: Company History

Mitsubishi Tanabe Pharma Corporation: Management Statement

Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries

Mitsubishi Tanabe Pharma Corporation: Key Competitors

Mitsubishi Tanabe Pharma Corporation: Company Analysis

Mitsubishi Tanabe Pharma Corporation: Business Description

Mitsubishi Tanabe Pharma Corporation: SWOT Analysis

Mitsubishi Tanabe Pharma Corporation: SWOT Overview

Mitsubishi Tanabe Pharma Corporation: Strengths

Mitsubishi Tanabe Pharma Corporation: Weaknesses

Mitsubishi Tanabe Pharma Corporation: Opportunities

Mitsubishi Tanabe Pharma Corporation: Threats

Mitsubishi Tanabe Pharma Corporation: Corporate Financial Deals Activity

Mitsubishi Tanabe Pharma Corporation: Financial Deals Overview

Mitsubishi Tanabe Pharma Corporation: Targets and Partners

Mitsubishi Tanabe Pharma Corporation: Top Deals 2016 - 2020YTD*

Mitsubishi Tanabe Pharma Corporation: Advisors

Mitsubishi Tanabe Pharma Corporation: Top Legal Advisors

Mitsubishi Tanabe Pharma Corporation: Top Financial Advisors

Mitsubishi Tanabe Pharma Corporation: Mergers and Acquisitions

Mitsubishi Tanabe Pharma Corporation: Partnership

Mitsubishi Tanabe Pharma Corporation: Divestments

Mitsubishi Tanabe Pharma Corporation: Private Equity and Ownership

Mitsubishi Tanabe Pharma Corporation: Recent Developments

Mitsubishi Tanabe Pharma Corporation: News and Events Summary

Mitsubishi Tanabe Pharma Corporation: Business Expansion

Mitsubishi Tanabe Pharma Corporation: Contracts

Mitsubishi Tanabe Pharma Corporation: Corporate Governance

Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events

Mitsubishi Tanabe Pharma Corporation: Research & Development

Mitsubishi Tanabe Pharma Corporation: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Mitsubishi Tanabe Pharma Corporation: Key Facts

Table 2: Mitsubishi Tanabe Pharma Corporation: Key Employees

Table 3: Mitsubishi Tanabe Pharma Corporation: Company History

Table 4: Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries

Table 5: Mitsubishi Tanabe Pharma Corporation: Key Competitors

Table 6: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 8: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size – Value (US$m)

Table 9: Mitsubishi Tanabe Pharma Corporation: Targets and Partners

Table 10: Mitsubishi Tanabe Pharma Corporation: Top Deals 2016 – 2020YTD*

Table 11: Mitsubishi Tanabe Pharma Corporation: Legal Advisor Ranking by Value (US$m)

Table 12: Mitsubishi Tanabe Pharma Corporation: Financial Advisor Ranking by Value (US$m)

Table 13: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2016 – YTD*2020)

Table 14: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2016 – YTD*2020)

Table 15: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 16: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 17: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2016 – YTD*2020)

Table 18: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2016 – YTD*2020)

Table 19: Mitsubishi Tanabe Pharma Corporation: Private Equity and Ownership Volume and Value Trend (2016 – YTD*2020)

Table 20: Mitsubishi Tanabe Pharma Corporation: Private Equity and Ownership Volume by Deal Type (2016 – YTD*2020)

Table 21: Mitsubishi Tanabe Pharma Corporation: News and Events Summary

Table 22: Mitsubishi Tanabe Pharma Corporation: Business Expansion

Table 23: Mitsubishi Tanabe Pharma Corporation: Contracts

Table 24: Mitsubishi Tanabe Pharma Corporation: Corporate Governance

Table 25: Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events

Table 26: Mitsubishi Tanabe Pharma Corporation: Research & Development

Table 27: Mitsubishi Tanabe Pharma Corporation: Strategy and Operations

List of Figures

List of Figures

Figure 1: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 3: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size – Value (US$m)

Figure 4: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2016 – YTD*2020)

Figure 5: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2016 – YTD*2020)

Figure 6: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 7: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2016 – YTD*2020)

Figure 8: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2016 – YTD*2020)

Figure 9: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2016 – YTD*2020)

Figure 10: Mitsubishi Tanabe Pharma Corporation: Private Equity and Ownership Volume and Value Trend (2016 – YTD*2020)

Figure 11: Mitsubishi Tanabe Pharma Corporation: Private Equity and Ownership Volume by Deal Type (2016 – YTD*2020)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports